The latest on the Harney Street bridge demolition, a U.S. Senator’s upcoming visit to Omaha, and more. Vermont Senator Bernie ...

The presentation of Cushing’s disease varies by age, with older adults having fewer hallmark features of the condition and ...

With a measles outbreak growing in West Texas, and cases popping up across the country, experts say vaccination is your best ...

Q4 2024 Earnings Call Transcript February 20, 2025 Dynavax Technologies Corporation reports earnings inline with expectations ...

Dynavax Technologies Corp (DVAX) reports record revenue for Heplisav-B, advances in vaccine programs, and strategic financial positioning despite rising R&D costs.

If you’ve had chickenpox, the virus that causes shingles is already inside your body. This is the case for 99% of adults over ...

Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.

HEPLISAV-B® 2024 net product revenue grew 26% year-over-year to $268 million; net product revenue expected to be $305 to $325 million in 2025 Top-line results in ...

Varicella, known as chickenpox, is caused by the varicella zoster virus (VZV), with an estimated 84 million cases annually. It primarily affects children, for most of whom it is a self-limiting ...

Receiving routine vaccinations against common infections like tetanus, shingles, and pneumonia may offer an unexpected ...